Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global reproductive toxicity testing market 3600 synopsis, 2018 – 2032
2.2 Regional trends
2.3 Product trends
2.4 Method trends
2.5 Technology trends
2.6 End-use trends
Chapter 3 Reproductive Toxicity Testing Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing demand for reproductive toxicology testing products
3.5.1.2 Increasing drug development and discovery
3.5.1.3 Rising usage of pharmacogenomics
3.5.1.4 Advancements in testing methods
3.5.2 Industry pitfalls & challenges
3.5.2.1 Dearth skilled professionals
3.5.2.2 High cost associated with reproductive toxicology testing and products
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By method
3.6.3 By technology
3.6.4 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Thermo Fisher Scientific, Inc.
4.1.2 Charles River Laboratories International
4.1.3 Eurofins Scientific
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Reproductive Toxicity Testing Market Estimates and Forecast, By Product (Revenue)
5.1 Key trends, by product
5.2 Consumables
5.3 Assays
5.3.1 Bacterial toxicity assays
5.3.2 Enzyme toxicity assays
5.3.3 Cell-based elisa & western blot
5.3.4 Receptor-binding assays
5.3.5 Tissue culture assays
5.3.6 Other assays
5.4 Equipment
5.5 Others
Chapter 6 Reproductive Toxicity Testing Market Estimates and Forecast, By Method (Revenue)
6.1 Key trends, by method
6.2 Cellular assays
6.3 Biochemical assays
6.4 In-silico models
6.5 Ex-vivo models
Chapter 7 Reproductive Toxicity Testing Market Estimates and Forecast, By Technology (Revenue)
7.1 Key trends, by technology
7.2 Cell culture technology
7.3 High-throughput technology
7.4 Toxicogenomics
Chapter 8 Reproductive Toxicity Testing Market Estimates and Forecast, By End-use (Revenue)
8.1 Key trends, by end-use
8.2 Academic and research institutes
8.3 Pharmaceutical and biotechnology companies
8.4 Contract research organizations
8.5 Others
Chapter 9 Reproductive Toxicity Testing Market Estimates and Forecast, By Region (Revenue)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Switzerland
9.3.7 The Netherlands
9.3.8 Denmark
9.3.9 Poland
9.3.10 Sweden
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 New Zealand
9.4.7 Thailand
9.4.8 Vietnam
9.4.9 Indonesia
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Colombia
9.5.5 Chile
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Turkey
Chapter 10 Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.2 Charles River Laboratories International
10.3 Laboratory Corporation of America Holdings
10.4 Eurofins Scientific
10.5 Jubilant Life Sciences Limited
10.6 Syngene International Limited
10.7 Gentronix Ltd.
10.8 Inotiv Inc.
10.9 Creative Bioarray
10.10 MB Research Laboratories
10.11 Bio-Rad Laboratories, Inc.
10.12 Catalent, Inc.
10.13 Evotec
10.14 QIAGEN
10.15 Promega Corporation
